Pregn-4-ene-3,20-dione,17-hydroxy-6-methyl-, (6a)-  cas no:520-85-4
         
           
           Synonyms:  Pregn-4-ene-3,20-dione,17-hydroxy-6a-methyl-(7CI,8CI); Progesterone, 17-hydroxy-6a-methyl- (6CI); 17-Hydroxy-6a-methylpregn-4-ene-3,20-dione;17-Hydroxy-6a-methylprogesterone;17a-Hydroxy-6a-methylprogesterone; 6a-Methyl-17-hydroxyprogesterone; 6a-Methyl-17R-hydroxyprogesterone;6a-Methyl-17a-hydroxypregn-4-ene-3,20-dione; 6a-Methyl-17a-hydroxyprogesterone; 6a-Methyl-4-pregnen-17a-ol-3,20-dione;Medoxyprogesterone; Medroxyprogesteron; Medroxyprogesterone; NSC 27408; U 8840
           
           
           
            
      
         
          
          NamePregn-4-ene-3,20-dione,17-hydroxy-6-methyl-, (6a)- 
            CAS520-85-4 
            SynonymsPregn-4-ene-3,20-dione,17-hydroxy-6a-methyl-(7CI,8CI); Progesterone, 17-hydroxy-6a-methyl- (6CI); 17-Hydroxy-6a-methylpregn-4-ene-3,20-dione;17-Hydroxy-6a-methylprogesterone;17a-Hydroxy-6a-methylprogesterone; 6a-Methyl-17-hydroxyprogesterone; 6a-Methyl-17R-hydroxyprogesterone;6a-Methyl-17a-hydroxypregn-4-ene-3,20-dione; 6a-Methyl-17a-hydroxyprogesterone; 6a-Methyl-4-pregnen-17a-ol-3,20-dione;Medoxyprogesterone; Medroxyprogesteron; Medroxyprogesterone; NSC 27408; U 8840
            EINECS(EC#)208-298-6 
            Molecular FormulaC22H32 O3
            
            Molecular Weight344.54 
            
            
         
          
            
            
            
            refractive index1.538 
            storage tempRefrigerator 
            
            
            
            
          
          
          
            Hazard Xn 
              Risk 48-63-68
              Safety 
    
        
    
    
        
An experimental teratogen. Experimental reproductive effects. A steroid. When heated to decomposition it emits acrid smoke and irritating fumes.
        Safety Information of Medroxyprogesterone (CAS NO.520-85-4):
        Hazard Codes: Xn.gif)
        Risk Statements: 48-63-68  
        48:  Danger of serious damage to health by prolonged exposure
        63:  Possible risk of harm to the unborn child 
        68:  Possible risk of irreversible effects
        Safety Statements: 22-24/25
        22:  Do not breathe dust   
        24:  Avoid contact with skin  
        25:  Avoid contact with eyes 
    
              
              
              
              
              
                    
       
      
          
            
    
        
    
    
        
        
            
                
                    | Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source | 
            
            
                
                    | women | TDLo | parenteral | 6mg/kg/13W-I (6mg/kg) | PERIPHERAL NERVE AND SENSATION: SENSORY CHANGE INVOLVING PERIPHERAL NERVE 
 BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"
 
 LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
 | Medical Journal of Australia. Vol. 163, Pg. 51, 1995. |